Literature DB >> 21872937

Smoking and strabismus surgery in patients with thyroid eye disease.

Rathie Rajendram1, Catey Bunce, Gillian G W Adams, Colin M Dayan, Geoffrey E Rose.   

Abstract

OBJECTIVE: To investigate the relationship between smoking status at presentation and the use of strabismus surgery in the management of patients with thyroid eye disease.
DESIGN: Retrospective review of a noncomparative series of patients with thyroid eye disease. PARTICIPANTS: All patients with thyroid eye disease under the care of a single consultant at Moorfields Eye Hospital between 1997 and 2002 (inclusive).
METHODS: Retrospective review of clinical case notes. MAIN OUTCOME MEASURES: Survival analysis of patients in cohort and the frequency of strabismus surgery in relation to smoking status at ophthalmic presentation. A subanalysis of patients who underwent orbital decompression and those that did not was undertaken.
RESULTS: Of 501 patients seen during the study period, 425 (85%) of 501 sets of notes were available for review, and initial smoking status was recorded for 89% (378/425) of patients, of whom approximately one half (196/378; 52%) were active smokers. Of the smokers, 51 (26%) of 196 underwent strabismus surgery, compared with only 19 (14%) of 138 nonsmokers at presentation. When adjusted for age, the hazards ratio of having strabismus surgery during management for smokers at presentation versus nonactive smokers was 2.19. In the group who did not undergo orbital decompression, this hazard ratio increased to 4.86.
CONCLUSIONS: Within this thyroid eye disease cohort, the proportion of smokers at presentation was much larger than that of the general population. There was an increased use of strabismus surgery in active smokers at presentation than in nonactive smokers. This finding was independent of the orbital decompression surgery. The results are consistent with those of previous reports of more severe thyroid eye disease in smokers and raise the possibility that smoking cessation early in the disease may reduce the severity of the changes and the number of rehabilitative strabismus operations needed. FINANCIAL DISCLOSURE(S): The author(s) have no proprietary or commercial interest in any materials discussed in this article.
Copyright © 2011 American Academy of Ophthalmology. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21872937     DOI: 10.1016/j.ophtha.2011.06.003

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  8 in total

Review 1.  Insulin-like Growth Factor-I Receptor and Thyroid-Associated Ophthalmopathy.

Authors:  Terry J Smith; Joseph A M J L Janssen
Journal:  Endocr Rev       Date:  2019-02-01       Impact factor: 19.871

Review 2.  Management of strabismus in thyroid eye disease.

Authors:  R Harrad
Journal:  Eye (Lond)       Date:  2014-12-19       Impact factor: 3.775

3.  Prognostic indicators for the development of strabismus among patients with graves' ophthalmopathy.

Authors:  Tiffany Y Lin; Ning Li; Michael W Yeh; Angela M Leung; Daniel B Rootman
Journal:  J Clin Transl Endocrinol       Date:  2017-07-11

4.  Intraoperative relaxed muscle positioning technique results in a tertiary Center for Thyroid Orbitopathy Related Strabismus.

Authors:  Ahmet Murat Sarici; Burak Mergen; Velittin Oguz; Cezmi Dogan
Journal:  BMC Ophthalmol       Date:  2018-11-23       Impact factor: 2.209

5.  The aryl hydrocarbon receptor pathway controls matrix metalloproteinase-1 and collagen levels in human orbital fibroblasts.

Authors:  Elisa Roztocil; Christine L Hammond; Mithra O Gonzalez; Steven E Feldon; Collynn F Woeller
Journal:  Sci Rep       Date:  2020-05-21       Impact factor: 4.379

6.  Therapeutic Effect of α-MSH in Primary Cultured Orbital Fibroblasts Obtained from Patients with Thyroid Eye Disease.

Authors:  Pei-Wen Cheng; Pei-Jhen Tsai; Ming-Hong Tai; Youn-Shen Bee
Journal:  Int J Mol Sci       Date:  2021-10-18       Impact factor: 5.923

7.  Predictors of the Dose-Effect Relationship regarding Unilateral Inferior Rectus Muscle Recession in Patients with Thyroid Eye Disease.

Authors:  Yasuhiro Takahashi; Hirohiko Kakizaki
Journal:  Int J Endocrinol       Date:  2015-06-28       Impact factor: 3.257

Review 8.  Management of Thyroid Eye Disease-Related Strabismus.

Authors:  Mohammad Reza Akbari; Arash Mirmohammadsadeghi; Raziyeh Mahmoudzadeh; Amirreza Veisi
Journal:  J Curr Ophthalmol       Date:  2020-03-23
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.